Reshape Lifesciences Inc (RSLS)
0.1693
-0.01
(-3.42%)
USD |
NASDAQ |
May 03, 16:00
0.171
0.00 (0.00%)
After-Hours: 20:00
Reshape Lifesciences Cash from Financing (Quarterly): 5.461M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.461M |
| September 30, 2023 | -0.338M |
| June 30, 2023 | 2.25M |
| March 31, 2023 | 10.20M |
| December 31, 2022 | 0.638M |
| September 30, 2022 | 0.003M |
| June 30, 2022 | 2.489M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -3.033M |
| June 30, 2021 | 35.33M |
| March 31, 2021 | 1.00M |
| December 31, 2020 | 5.069M |
| September 30, 2020 | 1.50M |
| June 30, 2020 | 2.031M |
| March 31, 2020 | 2.475M |
| December 31, 2019 | -1.398M |
| September 30, 2019 | 7.651M |
| June 30, 2019 | 5.427M |
| March 31, 2019 | 1.979M |
| December 31, 2018 | 22.49M |
| September 30, 2018 | 3.186M |
| June 30, 2018 | 7.531M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 17.98M |
| June 30, 2017 | 0.0162M |
| March 31, 2017 | 19.81M |
| December 31, 2016 | 0.005M |
| September 30, 2016 | -0.0421M |
| June 30, 2016 | 5.954M |
| March 31, 2016 | 10.14M |
| December 31, 2015 | 1.033M |
| September 30, 2015 | 13.50M |
| June 30, 2015 | -1.028M |
| March 31, 2015 | 5.452M |
| December 31, 2014 | -0.1599M |
| September 30, 2014 | -0.9979M |
| June 30, 2014 | 2.205M |
| March 31, 2014 | 6.746M |
| December 31, 2013 | 6.274M |
| September 30, 2013 | 2.332M |
| June 30, 2013 | -1.039M |
| March 31, 2013 | 12.06M |
| December 31, 2012 | 0.6036M |
| September 30, 2012 | 4.139M |
| June 30, 2012 | 11.18M |
| March 31, 2012 | -0.5504M |
| December 31, 2011 | -0.5248M |
| September 30, 2011 | 13.44M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-3.033M
Minimum
Sep 2021
35.33M
Maximum
Jun 2021
4.040M
Average
2.031M
Median
Jun 2020
Cash from Financing (Quarterly) Benchmarks
| Cutera Inc | -0.232M |
| Dynatronics Corp | 0.0223M |
| Stereotaxis Inc | 0.026M |
| Electromed Inc | 0.026M |
| Myomo Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.457M |
| Free Cash Flow | -17.00M |
| Free Cash Flow Per Share (Quarterly) | -0.1047 |
| Free Cash Flow to Equity (Quarterly) | -2.457M |
| Free Cash Flow to Firm (Quarterly) | -2.457M |
| Free Cash Flow Yield | -1.26K% |